FDA Targeting Kratom Manufacturer Based on Misleading Data

On February 2018, the FDA published the results of a basic computer model and misleadingly declared kratom an opioid, declaring it as a problem rather than a possible painkiller. It followed up within two weeks by issuing a “voluntary destruction” and recall to a Missouri-based manufacturer of more than 142,000 kratom-containing capsules, along with just … More FDA Targeting Kratom Manufacturer Based on Misleading Data